Fluvastatin

Spécifications

93957-54-1Numéro CAS

658-036-3Numéro CE

(E,3S,5R)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acidNom IUPAC

C24H26FNO4Formule chimique

411.5 g/molMasse molaire

fluvastatin; Fluvastatine; 93957-54-1; Fluvastatina; Fluvastatinum; CHEBI:5136; XU-62320; 4L066368AS; XU 62320; Fluvas; (3S,5R,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; CHEBI:38561; DTXSID2020636; NSC-758896; 6-HEPTENOIC ACID, 7-(3-(4-FLUOROPHENYL)-1-(1-METHYLETHYL)-1H-INDOL-2-YL)-3,5-DIHYDROXY-, (3R,5S,6E)-REL-; DTXCID0065309; (3S,5R,6E)-7-(3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl)-3,5-dihydroxyhept-6-enoic acid; RefChem:56568; C10AA04; 6-Heptenoic acid, 7-(3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-3,5-dihydroxy-, (R*,S*-(E))-(+-)-; 658-036-3; (E,3R,5S)-7-(3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl)-3,5-dihydroxyhept-6-enoic acid; 6-Heptenoic acid, 7-(3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-3,5-dihydroxy-, (3R,5S,6E)-; 155229-76-8; Fluvastatine [INN-French]; Fluvastatinum [INN-Latin]; Fluvastatina [INN-Spanish]; (3S,5R)-fluvastatin; (-)-3s,5r-fluvastatin sodium salt; CHEMBL350239; Fluvastatin (INN); (3S,5R,E)-7-(3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl)-3,5-dihydroxyhept-6-enoic acid; (E,3S,5R)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; FLUVASTATIN [INN]; Fluvastatin [INN:BAN]; UNII-4L066368AS; (+-)-fluvastatin; Fluvas (TN); Fluvastatin Impurity 13; FLUVASTATIN [MI]; Prestwick3_000859; FLUVASTATIN [VANDF]; rac-(3R,5S)-fluvastatin; SCHEMBL2847; BSPBio_000877; FLUVASTATIN [WHO-DD]; BIDD:GT0839; (-)-(3S,5R)-fluvastatin; (3S,5R)-(-)-fluvastatin; BPBio1_000965; orb1705076; CHEBI:94603; Fluvastatin Sodium - Impurity A; HSDB 8366; FJLGEFLZQAZZCD-JUFISIKESA-N; 6-Heptenoic acid, 7-(3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)- 3,5-dihydroxy-, (3R,5S,6E)-rel-; BDBM50248235; EBC-26993; AKOS015896650; DB01095; NSC 758896; NCGC00164604-08; NCGC00164604-10; DB-257706; C07014; D07983; T21405; EN300-28265959; BRD-K03602135-236-02-1; BRD-K39716612-236-01-1; (3S,5r,6e)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid; (3S,5R,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3S,5R,E)-7-(3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl)-3,5-dihydroxyhept-6-enoicacid; (6E)-erythro7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; 6-Heptenoic acid, 7-(3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)- 3,5-dihydroxy-, (R*,S*-(E))-(+-)-; erythro-(E)-3,5-dihydroxy-7-[3'-(4''-fluorophenyl)-1'-(1''-methylethyl)indol-2'-yl]hept-6-enoic acid; rac-(3R,5S,6E)-7-(3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-3,5-dihydroxy-6-heptenoic acid; rac-(3R,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acidSynonymes